← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2016Last known activity
Nov 30, 2023
Timeline
2010s
- Aug 22, 2016
Afimmune— Founded
Drugs by trial phase (1 distinct, 5 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT05861453Lead sponsorPhase 2Nov 30, 2023
- NCT04365400Lead sponsorPhase 2Sep 1, 2020
- NCT03452540Lead sponsorPhase 2Jun 30, 2018
- NCT03414541Lead sponsorPhase 2Sep 24, 2017
- NCT02941549Lead sponsorPhase 2Oct 1, 2016
Details
- Founded
- Dublin, IE Aug 22, 2016
- Last known activity
- Nov 30, 2023